SUPERIOR OUTCOMES FOR CHILDREN WITH RARE BLOOD DISORDERS
The Blood and Marrow Transplant Program at UCSF Benioff Children’s Hospitals is a leader in specialized treatment options for children with cancer. Our outstanding outcomes are the result of the efforts of our nationally and internationally recognized faculty, and the availability of cutting-edge clinical trials and therapies for patients with these rare disorders.
CONDITIONS TREATED
Malignant disorders- Acute leukemias and lymphomas
- High-risk neuroblastomas
- Brain tumors
- Other rare cancers
- Inborn errors of immunity, including primary immunodeficiency diseases and primary immune regulatory disorders
- Inborn errors of metabolism
- Bone marrow failure syndromes (acquired and genetic)
- Hemoglobinopathies
WHY REFER TO UCSF?
- Personalized care plans developed for each patient, tailored to their individual condition and status
- Cutting-edge treatments, such as gene therapy for genetic disorders, some of which are only available at UCSF Benioff Children’s Hospitals
- Multiple clinical trials available for access to novel therapies, including ancillary trials designed to improve supportive care and outcomes
- A unique multidisciplinary forum designed to optimize outcomes for immunocompromised critical care patients who require intensive support
- Multidisciplinary clinics for inborn errors of metabolism and chronic graft versus host disease
- Access to the Stad Center for Pediatric Pain, Palliative & Integrative Medicine, dedicated to relieving pain and improving quality of life for hospitalized children
- Clinical social workers provide emotional support and resource coordination for the whole family, including assistance with transportation and local lodging
- Child life specialists and creative arts therapists who develop positive health care experiences for hospitalized children and their families
- Availability of CAR T-cell and other novel immunotherapies, including first commercially available products from Novartis (Kymriah) and Kite (Yescarta)
INFORMATION / REFERRALS
- PHONE(415) 476-2188
- FAX(415) 502-4867
OUR TEAM
Christopher Dvorak, MD
Pediatric hematologist-oncologist
Chief, Division of Pediatric Allergy, Immunology, and BMT
Director, Pediatric Cellular Therapy Laboratory
Sandhya Kharbanda, MD
Pediatric hematologist-oncologist
Medical Director, Pediatric BMT Program, San Francisco
Julia Chu, MD, MPH
Pediatric hematologist-oncologist
Morton Cowan, MD
Pediatric immunologist
Jasmeen Dara, MD, MS
Pediatric immunologist
Michelle Hermiston, MD, PhD
Pediatric hematologist-oncologist
Director, Immunotherapy Program
Christine Higham, MD
Pediatric hematologist-oncologist
James Huang, MD
Pediatric hematologist-oncologist
Director, Pediatric Hematology
Janel Long-Boyle, PharmD, PhD
Pharmacotherapist
Alexis Melton, MD, PhD
Pediatric hematologist-oncologist
Director of Apheresis, San Francisco
Gabriel Salinas Cisneros, MD
Pediatric hematologist-oncologist
Kristin Shimano, MD
Pediatric hematologist-oncologist
Lena Winestone, MD, MS
Pediatric hematologist-oncologist
Matt Zinter, MD
Pediatric critical care specialist
